Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR1900023033Phase 4Recruiting
Phase 4, randomised, open-label trial of benzbromarone in hyperuricemia (2 arms), sponsored by Shanghai Ninth People's Hospital. Primary endpoint: Left ventricular diastolic function. Started Jan 2019; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR1900023033.